Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort

Conditions:   Influenza;   Hepatitis A;   Typhoid;   Healthy Adults Interventions:   Biological: Fluzone® quadrivalent;   Biological: Fluzone High Dose;   Biological: Fluad;   Biological: Vaqta;   Biological: Typhim Vi;   Biological: Vivotif Sponsors:   Stanford University;   National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials